Cardio-psycho-metabolic outcomes of bariatric surgery: design and baseline of the WAS trial

Cardio-psycho-metabolic outcomes of bariatric surgery: design and baseline of the WAS trial

Obesity is a rapidly emerging health problem and an established risk factor for cardiovascular diseases. Bariatric surgery profoundly reduces body weight and mitigates sequelae of obesity. The open, randomized controlled Würzburg Adipositas Studie (WAS) trial compares the effects of Roux-en-Y gastri...

Full description

Bibliographic Details
Main Authors: Ann-Cathrin Koschker, Bodo Warrings, Caroline Morbach, Florian Seyfried, Nicole Rickert, Pius Jung, Andreas Geier, Ulrich Dischinger, Maike Krauthausen, Martin J Herrmann, Christine Stier, Stefan Frantz, Uwe Malzahn, Stefan Störk, Martin Fassnacht
Format: Article
Language:English
Published: Bioscientifica 2022-02-01
Series:Endocrine Connections
Subjects:
randomized controlled trial
morbid obesity
roux-en-y gastric bypass
lifestyle intervention
heart failure
cardiovascular and brain function
quality of life
Online Access:https://ec.bioscientifica.com/view/journals/ec/11/2/EC-21-0338.xml

Internet

https://ec.bioscientifica.com/view/journals/ec/11/2/EC-21-0338.xml

Similar Items